Xevirol is Everolimus, an oral mTOR inhibitor. It is indicated for renal cell carcinoma, selected neuroendocrine tumors, and hormone receptor-positive breast cancer and works by blocking mTOR signaling involved in cell growth, proliferation, and angiogenesis.
| Product Name | Xevirol |
| Generic Name | Everolimus |
| Formulation | Tablet |
| Available Pack Size | 3X10's |
| Available Strength | 5 mg |